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Abstract 
T o  e x a mine the presence o f  s u b s tances which inhibi t  
calcification i n  human ligamentum flavum, the calcification 
inhibitory effect of human ligamentum flavum extract obtained by 
extraction of the tissue with 3% Na2HP04 was determined by the in 
vitro c a l c ium uptake of the ligamentum f l avum matrix. In 
addition, grafts of extracted and non-extracted dry ligamentum 
flavum matrices were transplanted into the dorsal muscles of 
rats, and calcification in the grafts was examined radiologically 
and histochemically. In order to determine whether or not 
component cells of human ligamentum flavum produce calcification 
inhibitors, ligamentum flavum cells were cultured, and the 
crystal inhibitor activity of the culture medium was measured by 
t h e  s e e d  t e s t  u s i ng h y d r o x ya p a t i t e a s  t h e  n u c l e u s  o f  
precipitation. The calcification react.ion system demonstrated 
that the ligamentum flavum extract contains an inhibitory factor 
for calcium uptake by the ligamentum flavum matrix. The seed 
test reve a led that human ligamentum f lavu m cells pro duce 
calcification inhibitor activity. The inhibitor activity was 
fractionated into two peaks by gel filtration of the culture 
medium. 
[Key words: Human ligamentum flavum, Calcification, Calcification 
inhibitors] 
Introduction 
Numerous substances are known to inhibit the formation and 
growth of calcium phosphate crystals in vitro (1 , 3) .  Among these 
substances, pyrophosphate, magnesium, citrate and albumin are 
believed to be involved in the regulation of various processes of 
mineralization in vivo (3) . In addition to these substances, it 
has been demonstrated that substances having in vitro crystal 
inhibitor activity are present in plasma ultrafiltrate (8, 10, 17) , 
urine (2, 8) , human saliva (7) , bone (14, 1 6 ) , cartilage (4) , fetal 
mice skin ( 9) , and connective tissues such as bovine and human 
Achilles tendons (15) . 
In 19 6 7 , Thomas and Tomita (19) found that extraction of 
bovine tendon with 3% Na2HP04 converts that tissue to a matrix 
capable of inducing calcification. Qui ttner and Wadkins ( 1 5) 
reported in 1978 that the inhibitory substance in the extract has 
a molecular weight of 85, 000-100, 000. Various factors regulating 
calcification are present in hard tissues. These factors include 
calcification inhibitors such as osteonectin ( 1 6) , osteocalcin 
(14) , proteoglycans (4) , and phosphoprotein (18) . In 1988, Ohya 
et al ( 1 3) obtained two fractions , a high molecular weight 
fraction and a low molecular weight fraction, which have in vitro 
calcification inhibitor activity from thE� medium of rat calvaria 
cell culture. 
In the present study, calcification inhibitors in the human 
ligamentum flavum were extracted and their inhibitor activity was 
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a s s e s s e d , o n  t h e  b a s i s  o f  t h e  f a c t  t h a t  t h e  c l i n i c a l  
manifestation of spinal stenosis can be caused by calcification 
and ossification of the ligamentum flavum. The production of 
calcification inhibitors by component cells of the ligamentum 
flavum was also examined. 
Materials and Methods 
Materials 
Lumbar ligamentum flavum, obtained during surgery from 63 
patients ranging in age from 18 to 80 years (mean 54+18 years) , 
were used in the present study. The patient group was comprised 
of 25 indi viduals with l u m b a r  d i s c  h e r niatio n ,  3 6  with 
degenerative lumbar spinal stenosis and 2 with cauda equina 
tumor. T h e  ligamentum f l a v u m  o b t a i n e d  d u r i n g  surgery was 
stripped of adventitious tissue as thoroughly as possible, rinsed 
with cold distilled water, and immediately frozen at -80° C. The 
total weight of the ligamentum flavum obtained was 121 g. 
Extraction of calcification inhibitors 
Accordi ng to the method s of Thomas and Tomita (19) and 
Quittner and Wadkins (15) , the ligamentum pieces, prepared after 
thawing the frozen specimen , were sus pended in 20 ml of 3% 
Na2HP04 per gram of ligament (containing 1. 0 mM NaN3) at pH 9. 2, 
and stirred slowly and continuously for 6 days at 4°C. The 
tissue w as then remov e d , a n d  the p h osphate e xtract was 
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lyophilized and dissolved in enough disi:illed water to obtain 
approximately 25% of its original volume. This solution was 
di alyzed aga inst distilled water at 3°C for 3 days , u s i ng 
cellulose dialysis tubing (Nacalai Tesque Inc, Kyoto) with an 
exclusion limit of 8, 000 daltons. After dialysis, the solution 
was lyophil ized to d ryness , and the d r y  res id ue was then 
suspended in distilled water and dialy zed repeatedly until 
inorganic phosphate reached a concentration of less than 0. 1 mM 
(p-methylaminophenol reduction method) . The solution thus 
o b t a i n e d  w a s  c e n t r i f u g e d  a t  1 0 0 , 0 0 0  G f o r  2 h ,  a n d  t h e  
supernatant was lyophilized to dryness to obtain the extract 
containing the inhibitor. 
Tissue extracted with 3% Na2HPO 4 and non-extracted tissue 
were rinsed with distilled water for 2 h at 4°C and lyophilized 
for use as matrices in the reaction system for calcification. 
Calcium u pt ake by the m at r i x  i n  the reaction syste m for 
calcification 
The in vitro crystal inhibitor activ.i ty of the extract was 
assayed in the following reaction system. A 100-mg of extracted 
or non-extracted ligamentum flavum matrix was added to 25 ml of a 
mixture of 17. 5 mM barbital buffer (pH 7. 4) , 125 mM NaCl, 2. 0 mM 
45cacl2 (350, 000-400, 000 cpm) (370 GBq-2. 77 TBq
/g calcium, New 
England Nuclear, Boston, MA) and 1. 2 mM potassium phospate (pH 
7. 4) . The mixture was stirred while incubating at 37c C. 2000 
�g streptomycin and 2000 units of penicillin were added to all 
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incubations. A t  2, 4,  6 ,  8 ,  12, 1 8,, 2 4 ,  36  and 4 8  h o f  
incubation, a 1 ml aliquot of the soluble phase was obtained, and 
the radioactivity was measured with a liquid scintillation 
counter (LS 3801, Beckman, U. S. A.) to determine the uptake of 
calcium by the matrix. In the reaction system using extracted 
matrices, changes in radioactivity in the presence of 16 mg of 
the ligamentum flavum extract, 1 mM NaF or phosvitin (250 j1g/ml) 
were also examined. 
Histological observation of calcification after transplantation 
of ligamentum flavum matrices 
Grafts of ligamentum flavum lyophilized before and after 
extraction were transplanted into the bilateral dorsal muscles of 
10 SD rats (Japan SLC, Shizuoka) . Each graft was trimmed as 
precisely as possible to the size of 5 x 5 x 3 mm, and sterilized 
with ethylene oxide gas. The bilateral dorsal muscles were 
incised symmetrically, and a graft prepared from non-extracted 
tissue was transplanted on the left side, and extracted graft on 
the right side. The fascia was not sutured. Two rats each were 
sacrificed 1, 2, 4, 8 and 12 weeks after transplantation, and the 
grafts on both sides were extirpated with the dorsal muscle. The 
specimens were immediately subjected to roentgenography using a 
Softex CSM-2 X-ray apparatus (Softex Co. , Tokyo) with Fuji Softex 
N 1 0 0  f i l m s  a t  5 0  KV, 1 2  rn A ,  fo r 4 s .  F o r  h i s t o l o g i c a l 
examination, the specimens were fixed in 10% neutral formalin, 
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embedded in paraffin, and cut into serial sections, 6 t m in 
thickness. The sections were then stained using hematoxylin­
eosin stain and von Kassa stain. 
Crystal inhibitor activity in ligamentum flavum cell culture 
system 
a. Cell culture 
T h e  ligamen tum flavum o b t a i ned d u r ing s u r g e ry from 23 
patients ranging in age from 20 to 78 years (mean: 52±1 7) were 
used. Each specimen was washed with saline immediately after the 
resection, followed by careful removal of the surface layer of 
the tissue under magnification. The tissue was digested in 0.1% 
trypsin (Wako Pure Chemicals, Tokyo) for 20 min, and treated with 
0. 05% collagenase (Wako Pure Chemicals, Tokyo) for 1 h at 37° C 
while stirring. After filtration through a #250 nylon mesh (Abe 
Science, Chiba) , the filtrate was centrifuged at 1, 000 rpm for 1 0  
min to separate cells. After washing three times with Ham's F1 2 
medium (Flow Laboratories, Inc. , McClean, VA) , cells were seeded 
at a cell density of 40, 000 cells/25-cm2 flask in 5 ml of Ham's 
F12 medium supplemented with 1 0% fetal calf serum (Bocknek, 
Toronto) and incubated at 37c C under a 5% co2-95% air atmosphere 
for 1 4-21  days until they became confluent. The cell layer was 
then washed three times with 0.9% (w/v) NaCl solution, and 5 ml 
o f  D u l b e c c o ' s m o d i f i e d e s s e n t i a l  m e d i u m  ( D M E M )  ( Flo w 
Laboratories, Inc. , )  supplemented with 0. 1 %  albumin (fatty acid­
free) . After 2 4 h of incubation under the same conditions, the 
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culture medium was collected and subjected to measurement of 
crystal inhibitor activity. DMEM supplemented with 0.1% albumin 
was kept for 24 h under the same conditions as those in the above 
cell culture, and used as the control. Streptomycin 1 0 0 j-1 g /ml 
and penicillin 100 U/ml were added to each medium. 
b. Measurement of crystal inhibitor activity (seed test) 
The crystal inhibitor activity was determined according to 
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the seed test described by Rufenacht and Fleisch ( 1 7) . First, 
the solubility of CaHPO 4 · 2H2o was determined by the following 
procedure. To DMEM, 50 mM HEPES (Doj in pharmacochemical Lab., 
Kumamoto) and 0.1% NaN3 (Wako Pure Chemicals, Osaka) were added, 
and the pH was adjusted to 7.4. A 0.5-ml sample of this medium 
was mixed with 2.5 mg of CaHPo4·2H2o in a 15-ml polystyrene tube 
(Corning 25311) (Iwaki Glass, Tokyo) and incubated at 37cC for 6 0  
min, using a shaker with a frequency of 300 rpm. The sample was 
then centrifuged at 7, 500 G for 4 min, and the concentrations of 
Ca2+ and i n o rganic p h o s p h ate ( P i )  in t h e  supern atant were 
determined by the ionic electrode method using an ionized calcium 
measuring apparatus (NOVA 2, Nova Biomedical, U.S.A.) and by p-
methylaminophenol reduction, respectively. Solutions of 0.33 M 
CaCl2 and 0.25 M Na2HP04 were added to the remaining portions of 
the above medium to adjust to the ca2+ and Pi concentrations 
determined. Hydroxyapatite (HAP) (Nippon Chemical, Tokyo) was 
added to 0.5 ml aliquots of the adjusted medium to prepare a 
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s e r i e s  o f  h y d r o x y a p a t i t e s u s p e n s i o n s  a t  11 d i f f e r e n t  
concentrations ranging from 0. 01 to 3.16 mg/ml. All samples were 
incubated at 37° C for 60 min while stirring and centrifuged at 
7, 500 G for 4 min. 
The ca2+ concentration of the supernatants was then measured 
by the ionic electrode method. The obtained values were plotted 
on the ordinate of a scale that linearizes the Gauss integral 
(probability paper) , whereas the logarithm of the amount of 
apatite added was plotted on the abscissa. From this plot, the 
amount of apatite necessary to induce a 50% decrease in the 
initial ca2+ concentration was obtained , and this value was 
regarded as the index of the crystal inhibitor activity of the 
sample. 
c. Crystal inhibitor activity of each medium fraction after gel 
filtration 
Ligamentum flavum obtained from a 21-year-old woman with 
lumbar disc herniation was used. The specimen was subjected to 
cell culture in Ham's F1 2 medium supplemented with 1 0% fetal calf 
serum, followed by DMEM medium not supplemented with serum or 
albumin. The DMEM medium cultured with ligamentum flavum cells 
was fractionated by column chromatography (column diameter: 1 .5 
em, height: 47 em) using Sephadex G25 (particle size: 50-150 pm, 
Pharmacia, Uppsala) , and the inhibitor activity of 20 fractions 
was determined by the seed test. Another DMEM not supplemented 
with serum or albumin was kept under the same conditions for 24 h 
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and used as the control. 
Results 
Calcium uptake by the ligamentum flavum matrix in the reaction 
system for calcification 
A total of 145 mg (dry weight) of human ligamentum flavum 
extract was obtained, corresponding to about 1.2 mg per gram of 
wet weight of ligamentum flavum. In the reaction system, calcium 
uptake by the extracted matrix increased �1ith time in a quadratic 
curve; the values were significantly hi9her than those in the 
non-extracted matrix. In the reaction system using an extracted 
matrix, calcium uptake was suppressed in the reaction solution 
(25 rnl) containing 16 rng of the extract (Fig. 1 ) .  Changes in 
calcium uptake in the presence of 1 mM NaF or 250 mg/ml phosvitin 
are shown in Fig. 2. NaF caused a marked increase in calcium 
uptake (open squares in Fig. 2) . A combination of NaF and 16 rng 
of the extract induced a slight decrease in uptake (closed 
squares in Fig. 2) . Phosvitin caused a far greater inhibition of 
uptake than did the extract (open triangles in Fig. 2) . 
Radiologic findings of the matrix transplantation in paraspinal 
muscles 
Grafts of extracted ligamentum flavum matrices showed an 
uneven opacity one week after the transplantation (Fig. 3-b) , and 
this finding was more conspicuous at 4 weeks (Fig. 3-d). The 
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shadows increased in opacity with time, showing a radial pattern 
of extension suggestive of crystalline 9rowth (Figs. 3-f, h) . 
The exten t  of shadows measur ed using a n  eye piece scale was 
clearly smaller than that in grafts of extracted tissue (Figs. 3-
a, c ,  e) , however, there were eviden tly calcified shadows in 
grafts of non-extracted ligamentum flavum matrices 12 weeks after 
transplantation {Fig. 3-g) . 
Histological findings 
Vascular connective tissue prolife ration accompanied by 
foreign body giant cell and round cell infiltration was found in 
the area surroundi ng the grafts of both extracted and non­
extracted matrices (Fig. 4) . These changes reached a peak at 2 
weeks, followed by mature connective tissue (Figs. 4, 5, 6 and 
7 ) 
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The transplanted rna trices had a fibrous structure with 
apertures of varying size. A few small round cells entered these 
apertures by 2 weeks after transplantation (Fig . 5) , but no 
extension of the cell infiltration was noi:ed with time. Although 
t h e re was a conside r a b le d i f fe re n cE� a m o ng i n div id u a l s ,  
calcification obse rved b y  v o n  K o s s a  stain w a s  generally 
m a nifested as small g r ains in the g r a f t  f r o m  1 w e ek a f ter 
transplantation, and the calcareous deposits became enlarged over 
time {Figs. 6 and 7) . 
observation period. 
There was no ossification throughout the 
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Crystal inhibitor activity in human ligamentum flavum cell 
culture 
In the seed test of media cultured with ligamentum flavum 
cells , the mean crystal inhibitor activity determined by the 
amount of hydroxyapatite (HAP) required to obtain 50% inhibition 
of calcification was 6 17. 8±182. 1 rg HAP/500 �1 (n=23) , whereas it 
was 372. 8+ 89. 6 fg HA P/500 rl with the control medium (n=7) 
(p<0. 01) (Table 1 ) .  When the inhibitor activity in relation to 
age was examined in three different age groups (20-40, 41-6 0, and 
6 1-78 years) , the inhibitor activity tended to increase with an 
increase in age, but the difference was not significant (Table 
2) . The seed test of fractions of the culture medium obtained by 
Sephadex G25 chromatography showed three peaks of inhibitor 
activity. The first peak agreed almost completely with the void 
volume, and the second peak was of lower molecular weight. The 
third peak almost corresponded to the only peak obtained with the 
control medium, suggesting a pre-existing Mg2+ (Fig. 8) . 
D iscus sion 
The concentration of calcium and phosphate in extracellular 
fluid s are supe rsatur ated with respect t o  h y droxya pa tite 
dissolution (11, 12) , but no calcification of connective tissue 
occurs under normal conditions, suggesting the existence of an 
inhibitory mechanism in the tissue. 
The calcification inhibitors in the present study were 
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extracted according to the methods of Thomas and Tomita (19) and 
Quittner and Wadkins (15) for the extracton of inhibitor in the 
Achilles tendon. In the present study however, since the amount 
of ligamentum flavum obtained during surgery from each patient 
was very sma ll ,  specimens from patients of various ages were 
pooled for extraction. In order to prevent contamination from 
blood, the ligamentum flavum specimens were carefully rinsed with 
distilled water immediately after removal. It is clear from the 
results that the human ligamentum flavum matrix after extraction 
with 3% Na2HP04 exhibits calcification activity. As pointed out 
by Quittner and Wadkins (15) , this change in the ligamentum 
flavum can be explained by the following two hypotheses� 1) 
phosphate specifically promotes dissociation from the tissue of 
substances calcification-inhibitory in situ, and 2) phosphate 
alone , o r  in c o m b i n a t i o n  w i t h  en d o g e n ous ca2+ , binds at 
appropriate sites of the matrix and thereby provides centers for 
nucleation and growth of calcium phosphate crystals. The results 
of the present study suggest that at least the substance which 
inhibits calcification was removed through the process of 
extraction. It is reported that the calcification inhibitor n 
bovine Achilles tendon has a peptidoglycan structure with a 
molecular weight of 85, 000-100, 000 (15) . In the present study, 
although identification and measurement of the molecular weight 
was not possible because of the limited specimens, the molecular 
weight is presumed to be greater than 8, 000 from the exclusion 
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limit of the cellulose dialysis tubing used. The addition of 1 
mM NaF to the calcification reaction system increased the calcium 
uptake by the matrix. These results are consistent with the 
previously reported f i n d i n g  t h a t  c a l c i u m  u p t a ke by the 
collagenous matrix from bovine Achilles tendon is stimulated by 
NaF in the range of 2 x 10-5 to 2 x 10-3 M (21 ) .  Wadkins and 
Luben (21) reported that the calcification process mediated by 
t h e  c o l l a g e n o u s  m a t r i x i s  l e s s  s e n s i t i v e  t o  
methylenediphosphonate and phosphonoacetate in the presence of 
NaF. This coincides with the results of the ligamentum flavum 
extract examined in the present study. It is therefore possible 
that the ligamentum flavum extract inhibits calcification through 
a mechanism similar to t h a t  o f  met h y l e ne di p h osphonate or 
phosphonoacetate. 
Phosvi tin , a phosphoprotein in egg yolk, has a molecular 
weight of 20, 000-30, 000. According to Quittner and Wadkins (15) , 
phosvitin inhibits calcification mediated by matrix from bovine 
Achilles tendon, showing 6 7% inhibition at 100 1�g/ml, and 78% (at 
2 hat 200 f g/ml. The promotion of calcification by NaF and the 
potent inhibitor activity of phosvitin found in the present study 
are consistent with the findings obtained in bovi ne Achilles 
tendons by Quittner and Wadkins (15) and Wadkins and Luben (21 ) .  
The above-mentioned in vitro results are consistent with the 
histological findings obtained in the human ligamentum flavum 
rna trix transplanted into the dorsal muscles of rats. However, 
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the fact that calcification also occurred in the grafts of non­
extracted ligamentum flavum tissues at a later stage suggests 
that the substance extracted with 3% Na2HP04 does not interfere 
with every step of the calcification process. 
The crystal inhibitor activity of the culture medium from 
human ligamentum flavum cell culture, as determined by the seed 
test indicated that the cultured cells produce inhibitors for the 
formation of calcium phosphate crystals. In this exper imen ta 1 
system, there was no significant relationship between age and the 
inhibitor activity of the ligamentum flavum� the values were 
nearly constant. Thus, it seems that the inhibitors in the 
culture medium are not related to age (Table 2) . The inhibitor 
activity was separated into three peaks after gel filtration� the 
first and second peaks (indicated by arro\�S in Fig. 8) represent 
inhibitors produced by the culture cells. The third peak seems 
to indicate the inhibitor activity of pre-existing Mg2+ in the 
medium. O h y a  et al ( 13) d em o nstrated t hr ee p e aks o f  t he 
inhibitor activity, corresponding to a high molecular weight of 
over 4, 000, a low molecular weight and magnesium, by Bio-Gel P4 
column chromatography of the culture medium from rat carvarium 
cell culture. They speculated that the high molecular weight 
inhibitor activity might originate either from the substances 
that are absorbed onto bone mineral from body fluids, or from 
soluble components of the matrix. They also pointed out the 
possibility that the culture cells produce non-collagenous bone 
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proteins such as osteocalcin, osteonectin, proteoglycans or 
phosphoprotei n. With regard to the low molec u l a r  w e i g h t  
fraction, Ohya et al stated that pyrophosphate and citrate are 
present at low concentrations, and show negligible activities, 
and that most of the activity originates from other unknown 
inhibitors (13) . In plasma ultrafiltrate, magnesium, citrate and 
pyrophosphate are reported to r e p r e s ent only p ar t  o f  the 
inhibitor activity, indicating the presence of unknown inhibitors 
( 10) . Alth ough the i n h ibitors i n  t h e  p resent st udy w h i c h  
separated into two fractions are also unknown, it is possible 
that proteoglycans and phosphoprotein are included. 
It is considered that, unlike simple precipitation of 
c al c i u m  p ho s p hate crysta ls from s o l u t io n ,  the biological 
mechanism of calcification consists of mutual relationships among 
cells forming calcified tissues, organic matrices, minerals and 
regulatory factors ( 1, 3, 6 , 11 , 1 2, 20) . Various hypotheses have 
been proposed for the in vivo calcification mechanism. In one 
hypothesis , it is speculated that biological tissues have an 
inhibitory me chanism f o r  the p r e c i p i t ation of minerals 
(1, 3, 5, 11, 12) , and that the inhibition ceases when hard tissues 
are formed. Although this hypothesis cannot explain the entire 
process of calcification, a distinct inhibitory mechanism for 
calcification in human ligamentum flavum has been shown. Thus, 
it appears that changes in this mechanism are involved in the 
clinical cases of calcification or ossification of the ligamentum 
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flavum. 
The present study was supported by a Grand-in-Aid from the 
Research on Ossification of the Spinal Ligaments of The Japanese 
Ministry of Health and Welfare from 1988 to 1990. 
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legends for illustrations 
Fig. 1. Crystal inhib i tor acti vi ty of the ligame ntum f l avum 
extract: o---o Time-course changes in calcium uptake by 1 00 mg of 
extracted ligamentum flavum matrix (n=3), • • changes in the 
p r e s e n c e o f  1 6  m g  o f  l i g a m e n t u m f l a v u m  e x t r a c t  ( n = 3 ) ,  
�changes by non-extracted ligamentum f lavum matrix (100 mg) 
( n= 3 ) . 
Fig. 2. Ef fects of 1 mM NaF and 6 .25 mg phosvitin on the reaction 
system f or calcification: o---o Time-course changes in calcium 
uptake by 100 mg of extracted ligamentum matrix, .__ --e changes in 
the presence of 16 mg of ligamentum f lavum extract, o--a changes 
in the presence of 1 mM NaF, • I changes in the presence of 16 
mg of ligamentum flavum extract and 1 mM NaF, t:r---6. changes in 
the presence of 6 .25 mg of phosvitin. 
Fig. 3. Softex images of extracted and non-extracted ligamentum 
f lavum matrices af ter transplantation into the dorsal muscles in 
rats. a) non-extracted matrix at 1 week1, b) extracted matrix at 
1 week, c) non-extracted matrix at 4 weeks, d) extracted matrix 
at 4 weeks, e) non-extracted matrix at 8 weeks, f )  extracted 
ma trix at 8 weeks, g) non-extracted m a trix at 12 weeks, h) 
extracted matrix at 12 weeks. 
Fig. 4. Histological appearance of the peripheral area of non­
extracted ligamentum flavum matrix 4 weeks after transplantation. 
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Non-specific fibrous reaction and foreign body giant cells can be 
seen. (H. E. , x 1 00) 
Fig. 5. Hi stological p ictures o f  e x t r a c t ed ( A )  a nd n o n-
extracted ( B )  ligamentum f l av u m  matrices 2 weeks after 
transplantation. A) Calcareous deposits can be seen in the outer 
layer of t h e  graft. M a r ke d  round c e l l  infiltration and 
proliferation of vascular connective tissue are evident in the 
peripheral area of the graft (H. E. ,  x 40) . B) No calcareous 
deposits are detectable in the graft. (H. E .. , x 40) . 
Fig. 6. von Kassa stained pictures of extracted (A) and non­
extracted (B) ligamentum flavum m a t r ic es 2 weeks a f ter 
transplantation. A) Calcareous deposits are more numerous in the 
outer layer of the matrix (x 40) . B) Calcification deposits are 
present in a part of the graft, but are clearly less conspicuous 
than those in (A) (x 40) . 
Fi g. 7. Hi stological p i c t ures o f  extrac ted ( A )  and n o n -
extracted ( B )  ligamentum flavum matrices 8 weeks after 
transplantation. 
throughout the 
A) Numerous calcareous deposits are distributed 
entire graft . Cellular infiltration in the 
peripheral area of the graft has disappeared (von Kossa, x 40) . 
B) Calcareous deposits are located in only a part of the graft. 
There is almost no cellular infiltration in the peripheral area 
of the graft (von Kossa, x 40) . 
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Fig. 8. Crystal inhibitor activity of each fraction obtained by 
column chromatography of medium cultured with ligamentum flavum 
cells (s eed test). Culture medium (3 ml) was separated on a 
Sephadex G 25 column (1.5 x 4 7  ern), and the crystal inhibitor 
activity of each fraction (3 rnl) is expressed in the amount (f_.tg) 
of hydroxyapatite. ••----• Culture medium from ligamentum flavurn 
cell culture. Arrows indicate the fractions having inhibitor 
activity specific to this medium. 0-----o Control medium. The 
peak centering on the fraction number 21 seems to represent the 
inhibitor activity of Mg2+. 
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